Free Trial
ASX:NVO

Novo Resources (NVO) Stock Price, News & Analysis

Novo Resources logo

About Novo Resources Stock (ASX:NVO)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive NVO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Novo Resources and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

NVO Stock News Headlines

Ozempic maker Novo Nordisk is cutting 9,000 jobs
IRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?
On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed professionals, retirees, and high-net-worth savers. But the wealthy aren’t just writing checks. They’re moving fast to protect capital and purchasing power using legal, IRS-compliant strategies. American Alternative Assets just released the Mar-A-Lago Accord, a free guide revealing how to reduce Q3 tax exposure and reposition wealth before it’s drained.tc pixel
See More Headlines

NVO Stock Analysis - Frequently Asked Questions

Based on aggregate information from My MarketBeat watchlists, some other companies that Novo Resources investors own include Meta Platforms (META), Kosmos Energy (KOS), Lowe's Companies (LOW), Moderna (MRNA), NVIDIA (NVDA), UiPath (PATH) and Avidity Biosciences (RNA).

Industry, Sector and Symbol

Stock Exchange
ASX
Industry
Gold
Sub-Industry
Pharmaceutical Products
Current Symbol
ASX:NVO
CIK
N/A
Fax
N/A
Employees
54,400
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
A($0.14)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-A$44.85 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-35.92%
Return on Assets
-13.66%

Debt

Debt-to-Equity Ratio
0.62
Current Ratio
1.93
Quick Ratio
4.30

Sales & Book Value

Annual Sales
A$2.50 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
2.25
Book Value
A$0.23 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
354,630,000
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
1.48
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

This page (ASX:NVO) was last updated on 9/14/2025 by MarketBeat.com Staff
From Our Partners